Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Microbiome of barrier organs in allergy: Who runs the world? Germs!
In:. Berlin ; Heidelberg: Springer, 2021. DOI: 10.1007/164_2021_478 (Handb. Exp. Pharmacol.)
Over the last few decades, allergic diseases have been steadily increasing worldwide, a phenomenon that is not yet completely understood. Recent evidence, however, suggests that alterations in the microbiome may be a contributing factor. The microbiome refers to all microorganisms in a habitat including bacteria, fungi, and viruses. Using modern sequencing technologies, we are now capable of detecting and analyzing the human microbiome in more detail than ever before. Epidemiological and experimental studies have indicated that a complex intestinal microbiome supports the development of the immune system during childhood, thus providing protection from allergic diseases, including food allergy. The microbiome becomes an important part of human physiology and forms dynamic relationships with our various barrier systems. For example, bacterial dysbiosis is a hallmark of atopic eczema and correlates with disease progression. Similarly, the lung and nasopharyngeal microbiome is altered in patients with asthma and allergic rhinitis. While these results are interesting, the underlying mechanisms are still unclear and need to be investigated with functional studies. This review gives a short overview of the terminology and methods used in microbiome research before highlighting results concerning the lung, skin, and intestinal microbiome in allergic diseases.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Sammelbandbeitrag/Buchkapitel
Schlagwörter
Allergy ; Microbiome ; Sequencing
ISSN (print) / ISBN
0171-2004
Zeitschrift
Handbook of Experimental Pharmacology
Verlag
Springer
Verlagsort
Berlin ; Heidelberg
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Environmental Medicine (IEM)